EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro

Mary S Dickinson iD, Miriam Kutsch iD, Linda Sistemich iD, Dulcemaria Hernandez, Anthony S Piro, David Needham iD, Cammie F Lesser iD, Christian Herrmann iD, Jörn Coers iD

Proceedings of the National Academy of Sciences · 11.04.2023 · 120 (15)

DOI: 10.1073/pnas.2216028120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.04.2023. Verfasst von Mary S Dickinson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710. Hauptthemen laut MEDLINE: GTP-Binding Proteins, Lipopolysaccharides. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gamma-interferon (IFNγ)-inducible guanylate-binding proteins (GBPs) promote host defense against gram-negative cytosolic bacteria in part through the induction of an inflammatory cell death pathway called pyroptosis. To activate pyroptosis, GBPs facilitate sensing of the gram-negative bacterial outer membrane component lipopolysaccharide (LPS) by the noncanonical caspase-4 inflammasome. There are seven human GBP paralogs, and it is unclear how each GBP contributes to LPS sensing and pyroptosis induction. GBP1 forms a multimeric microcapsule on the surface of cytosolic bacteria through direct interactions with LPS. The GBP1 microcapsule recruits caspase-4 to bacteria, a process deemed essential for caspase-4 activation. In contrast to GBP1, closely related paralog GBP2 is unable to bind bacteria on its own but requires GBP1 for direct bacterial binding. Unexpectedly, we find that GBP2 overexpression can restore gram-negative-induced pyroptosis in GBP1 KO cells, without GBP2 binding to the bacterial surface. A mutant of GBP1 that lacks the triple arginine motif required for microcapsule formation also rescues pyroptosis in GBP1 KO cells, showing that binding to bacteria is dispensable for GBPs to promote pyroptosis. Instead, we find that GBP2, like GBP1, directly binds and aggregates “free” LPS through protein polymerization. We demonstrate that supplementation of either recombinant polymerized GBP1 or GBP2 to an in vitro reaction is sufficient to enhance LPS-induced caspase-4 activation. This provides a revised mechanistic framework for noncanonical inflammasome activation where GBP1 or GBP2 assembles cytosol-contaminating LPS into a protein-LPS interface for caspase-4 activation as part of a coordinated host response to gram-negative bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP-Binding ProteinsLipopolysaccharidesHumansCapsulesCarrier ProteinsInflammasomesInterferon-gammaPyroptosisCaspases, Initiator

Stichwörter der Autor:innen

cell-autonomous immunityguanylate-binding proteinsinflammasomeinterferon-stimulated geneslipopolysaccharide

Substanzen

CapsulesCarrier ProteinsGBP1 protein, humanGBP2 protein, humanGTP-Binding ProteinsInflammasomesInterferon-gammaLipopolysaccharidesCaspases, Initiator

Autor:innen und Institutionen

  • Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.
  • Department of Physical Chemistry I, Ruhr-University Bochum, 44801 Bochum, Germany.
  • Department of Mechanical Engineering and Material Science, Duke University, Durham, NC 27708.
  • Center for Bacterial Pathogenesis, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02139.
  • Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
  • Department of Immunology, Duke University Medical Center, Durham, NC 27710.

ORCID-Profile: Mary S Dickinson, Miriam Kutsch, Linda Sistemich, David Needham, Cammie F Lesser, Christian Herrmann, Jörn Coers

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • Deutsche Forschungsgemeinschaft
  • Burroughs Wellcome Fund

Zitieren

APA

Dickinson, M. S., Kutsch, M., Sistemich, L., Hernandez, D., Piro, A. S., Needham, D., Lesser, C. F., Herrmann, C., & Coers, J. (2023). LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro. Proceedings of the National Academy of Sciences, 120(15). https://doi.org/10.1073/pnas.2216028120

Vancouver

Dickinson MS, Kutsch M, Sistemich L, Hernandez D, Piro AS, Needham D, et al. LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro. Proceedings of the National Academy of Sciences. 2023;120(15). doi:10.1073/pnas.2216028120

BibTeX
@article{Dickinson2023,
  author = {Dickinson, Mary S and Kutsch, Miriam and Sistemich, Linda and Hernandez, Dulcemaria and Piro, Anthony S and Needham, David and Lesser, Cammie F and Herrmann, Christian and Coers, Jörn},
  title = {LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {15},
  doi = {10.1073/pnas.2216028120}
}
Kostenlos starten →